INSMED INC Financing Cash Flow
INSMED INC (INSM) reported Financing Cash Flow of $56.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- INSMED INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $27.18M, a 96.83% decline year-over-year.
- INSMED INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $29.51M, a 1.78% increase year-over-year.
- INSMED INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $33.86M, a 78.75% decline year-over-year.
- INSMED INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $33.41M, a 91.59% decline year-over-year.
- INSMED INC net cash provided by (used in) financing activities for fiscal 2025 was $954.07M, a 28.85% decline from fiscal 2024.
- INSMED INC net cash provided by (used in) financing activities for fiscal 2024 was $1.34B, a 696.15% increase from fiscal 2023.
- INSMED INC net cash provided by (used in) financing activities for fiscal 2023 was $168.44M, a 78.77% decline from fiscal 2022.
- INSMED INC net cash provided by (used in) financing activities for fiscal 2022 was $793.27M, a 29.50% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $56.69M 10-Q · filed 2026-08-06 | $90.55M derived: sum of 3 quarters · filed 2026-08-06 | $123.96M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $29.51M 10-Q · filed 2026-05-07 | $63.37M derived: sum of 2 quarters · filed 2026-05-07 | $96.78M derived: sum of 3 quarters · filed 2026-05-07 | $954.59M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $33.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $67.27M derived: sum of 2 quarters · filed 2026-02-19 | $925.08M derived: sum of 3 quarters · filed 2026-08-06 | $954.07M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $33.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $891.22M derived: sum of 2 quarters · filed 2026-08-06 | $920.21M 10-Q · filed 2025-10-30 | $1.08B derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $857.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $886.80M 10-Q · filed 2026-08-06 | $1.05B derived: sum of 3 quarters · filed 2026-08-06 | $1.44B derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $29.00M 10-Q · filed 2026-05-07 | $188.30M derived: sum of 2 quarters · filed 2026-05-07 | $585.50M derived: sum of 3 quarters · filed 2026-05-07 | $1.37B derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $159.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $556.50M derived: sum of 2 quarters · filed 2026-02-19 | $1.34B derived: sum of 3 quarters · filed 2026-02-19 | $1.34B 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $397.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.18B derived: sum of 2 quarters · filed 2025-10-30 | $1.18B 10-Q · filed 2025-10-30 | $1.30B derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $781.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $784.51M 10-Q · filed 2025-08-07 | $907.78M derived: sum of 3 quarters · filed 2026-02-19 | $909.03M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $3.02M 10-Q · filed 2025-05-08 | $126.28M derived: sum of 2 quarters · filed 2026-02-19 | $127.53M derived: sum of 3 quarters · filed 2026-02-19 | $171.86M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $123.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $124.51M derived: sum of 2 quarters · filed 2026-02-19 | $168.84M derived: sum of 3 quarters · filed 2026-02-19 | $168.44M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $45.58M derived: sum of 2 quarters · filed 2024-10-31 | $45.18M 10-Q · filed 2024-10-31 | $788.56M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | $44.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $43.93M 10-Q · filed 2024-08-08 | $787.31M derived: sum of 3 quarters · filed 2025-02-20 | $824.43M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | -$399.00K 10-Q · filed 2024-05-09 | $742.99M derived: sum of 2 quarters · filed 2025-02-20 | $780.10M derived: sum of 3 quarters · filed 2025-02-20 | $786.41M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | $743.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $780.50M derived: sum of 2 quarters · filed 2025-02-20 | $786.81M derived: sum of 3 quarters · filed 2025-02-20 | $793.27M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $37.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $43.43M derived: sum of 2 quarters · filed 2023-10-26 | $49.89M 10-Q · filed 2023-10-26 | $55.60M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-06-30 | $6.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $12.77M 10-Q · filed 2023-08-03 | $18.48M derived: sum of 3 quarters · filed 2024-02-22 | $21.02M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-03-31 | $6.46M 10-Q · filed 2023-05-04 | $12.17M derived: sum of 2 quarters · filed 2024-02-22 | $14.71M derived: sum of 3 quarters · filed 2024-02-22 | $612.30M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $8.25M derived: sum of 2 quarters · filed 2024-02-22 | $605.84M derived: sum of 3 quarters · filed 2024-02-22 | $612.55M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $600.13M derived: sum of 2 quarters · filed 2022-10-27 | $606.84M 10-Q · filed 2022-10-27 | $618.85M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | $597.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $604.30M 10-Q · filed 2022-08-04 | $616.31M derived: sum of 3 quarters · filed 2023-02-23 | $622.41M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | $6.70M 10-Q · filed 2022-05-05 | $18.71M derived: sum of 2 quarters · filed 2023-02-23 | $24.82M derived: sum of 3 quarters · filed 2023-02-23 | $275.57M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $12.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $18.11M derived: sum of 2 quarters · filed 2023-02-23 | $268.87M derived: sum of 3 quarters · filed 2023-02-23 | $271.00M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $256.86M derived: sum of 2 quarters · filed 2021-10-28 | $258.99M 10-Q · filed 2021-10-28 | $268.23M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2020-06-30 | $250.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $252.89M 10-Q · filed 2021-08-05 | $262.13M derived: sum of 3 quarters · filed 2022-02-17 | $263.49M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2020-03-31 | $2.13M 10-Q · filed 2021-05-06 | $11.37M derived: sum of 2 quarters · filed 2022-02-17 | $12.73M derived: sum of 3 quarters · filed 2022-02-17 | $284.36M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2019-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $10.60M derived: sum of 2 quarters · filed 2022-02-17 | $282.23M derived: sum of 3 quarters · filed 2022-02-17 | $285.28M 10-K · filed 2022-02-17 | |||
| 2019-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $272.99M derived: sum of 2 quarters · filed 2020-10-29 | $276.04M 10-Q · filed 2020-10-29 | $278.46M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $271.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $274.68M 10-Q · filed 2020-08-06 | $277.11M derived: sum of 3 quarters · filed 2021-02-25 | $277.71M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $3.05M 10-Q · filed 2020-04-30 | $5.47M derived: sum of 2 quarters · filed 2021-02-25 | $6.08M derived: sum of 3 quarters · filed 2021-02-25 | $11.63M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.03M derived: sum of 2 quarters · filed 2021-02-25 | $8.58M derived: sum of 3 quarters · filed 2021-02-25 | $386.74M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $605.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $6.15M derived: sum of 2 quarters · filed 2019-10-30 | $384.32M 10-Q · filed 2019-10-30 | $384.95M 10-Q · filed 2018-10-30 | $384.75M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $5.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $383.71M 10-Q · filed 2019-08-01 | $384.34M 10-Q · filed 2018-08-02 | $384.15M derived: sum of 3 quarters · filed 2020-02-25 | $762.37M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $378.17M 10-Q · filed 2019-05-07 | $378.79M 10-Q · filed 2018-05-02 | $378.60M derived: sum of 2 quarters · filed 2020-02-25 | $756.82M derived: sum of 3 quarters · filed 2020-02-25 | $758.69M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $378.65M derived: sum of 2 quarters · filed 2020-02-25 | $380.52M derived: sum of 3 quarters · filed 2020-02-25 | $381.09M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $378.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $380.09M derived: sum of 2 quarters · filed 2018-10-30 | $380.66M 10-Q · filed 2018-10-30 | $401.51M derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.43M 10-Q · filed 2018-08-02 | $23.29M derived: sum of 3 quarters · filed 2019-02-22 | $32.98M derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-03-31 | $565.00K 10-Q · filed 2018-05-02 | $21.42M derived: sum of 2 quarters · filed 2019-02-22 | $31.11M derived: sum of 3 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $20.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $30.55M derived: sum of 2 quarters · filed 2019-02-22 | $30.67M 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | $9.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $9.82M 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | $128.00K 10-Q · filed 2017-08-03 | ||||||
| 2015-12-31 | $227.80M 10-K · filed 2018-02-23 | ||||||
| 2012-12-31 | $10.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $35.76M derived: sum of 2 quarters · filed 2013-03-18 | $45.46M derived: sum of 3 quarters · filed 2013-03-18 | $45.42M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $25.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $35.33M derived: sum of 2 quarters · filed 2012-11-07 | $35.29M 10-Q · filed 2012-11-07 | $35.28M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2012-06-30 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $9.66M 10-Q · filed 2012-08-07 | $9.65M derived: sum of 3 quarters · filed 2013-03-18 | $9.62M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2012-03-31 | -$34.00K 10-Q · filed 2012-05-08 | -$52.00K derived: sum of 2 quarters · filed 2013-03-18 | -$74.00K derived: sum of 3 quarters · filed 2013-03-18 | -$63.00K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$40.00K derived: sum of 2 quarters · filed 2013-03-18 | -$29.00K derived: sum of 3 quarters · filed 2013-03-18 | -$50.00K 10-K · filed 2013-03-18 | |||
| 2011-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$11.00K derived: sum of 2 quarters · filed 2012-11-07 | -$32.00K 10-Q · filed 2012-11-07 | -$35.00K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$10.00K 10-Q · filed 2012-08-07 | -$13.00K derived: sum of 3 quarters · filed 2013-03-18 | -$13.00K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | -$21.00K 10-Q · filed 2012-05-08 | -$24.00K derived: sum of 2 quarters · filed 2013-03-18 | -$24.00K derived: sum of 3 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$3.00K derived: sum of 2 quarters · filed 2013-03-18 | -$233.00K 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$230.00K 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | -$230.00K 10-Q/A · filed 2011-08-08 | ||||||
| 2009-12-31 | $2.88M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |